LI
CS001P3
Phase 3 mab completed
Quick answer
LI for Squamous Cell Carcinoma of the Oral Cavity is a Phase 3 program (mab) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Indication
- Squamous Cell Carcinoma of the Oral Cavity
- Phase
- Phase 3
- Modality
- mab
- Status
- completed